All posts by: Michael Zand

About Michael Zand

Creative Biolabs Announced Bio-distribution Analysis Services for CAR-T Cell Therapy – Digital Journal

Continue reading

2017-11-24 NEWS

Korea Biomedical Review

Creative Biolabs Announced Bio-distribution Analysis Services for CART Cell Therapy
Digital Journal
“All the time, we commit ourselves to promoting the development of CART cell immunotherapy. We all know that CART cell immunotherapy has received huge success for treating hematological malignancies. However, we can’t deny that there still remains a …
Clinical trials on CART cell therapies surge in two yearsKorea Biomedical Review

all 3 news articles »

Continue reading

2017-11-24 NEWS

Korea Biomedical Review

Creative Biolabs Announced Bio-distribution Analysis Services for CART Cell Therapy
Digital Journal
“All the time, we commit ourselves to promoting the development of CART cell immunotherapy. We all know that CART cell immunotherapy has received huge success for treating hematological malignancies. However, we can’t deny that there still remains a …
Clinical trials on CART cell therapies surge in two yearsKorea Biomedical Review

all 3 news articles »

Continue reading

2017-11-24 NEWS

Herald Sun

Melbourne researchers exploring gene therapy ‘turbo boost’
Herald Sun
The Institute is modifying viruses to deliver a gene therapy to reprogram muscle cells. The team, funded by the National Health and Medical Research Council for the next four years, is aiming to build a case for human clinical trials. “Our hope is that

Continue reading

2017-11-24 NEWS

Asian Scientist Magazine

Asia’s Rising Scientists: Matthew Chang
Asian Scientist Magazine
As the director of the Synthetic Biology for Clinical and Technological Innovation (SynCTI) program at the National University of Singapore (NUS), Chang works at the interface of biology and engineering, stewarding a multidisciplinary team to develop …

Continue reading

2017-11-24 NEWS

Weekly Register

Editas Medicine (EDIT) & CytRx Corporation (CYTR) Head-To-Head Analysis
Dispatch Tribunal
CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Francisella 1 (Cpf1), bound to a guide RNA molecule designed to recognize a particular …
Zacks’ 7 Best Strong Buys for 2018Zacks.com
SEC FORM 4 – SEC.govSEC.gov

all 38 news articles »